M
34
-5
MO
57
3
HRB
61
9
TEL
58
-2
RL
79
-4
AZO
63
-2
MTCH
46
-2
DVA
46
-3
NWL
33
-2
ALLE
46
2
FLR
65
10
PYPL
64
-6
KSS
36
-5
CMCSA
42
-2
PEG
57
4
DTE
54
5
EQR
31
-2
A
44
-2
URI
58
-2
ORLY
57
4
M
34
-5
MO
57
3
HRB
61
9
TEL
58
-2
RL
79
-4
AZO
63
-2
MTCH
46
-2
DVA
46
-3
NWL
33
-2
ALLE
46
2
FLR
65
10
PYPL
64
-6
KSS
36
-5
CMCSA
42
-2
PEG
57
4
DTE
54
5
EQR
31
-2
A
44
-2
URI
58
-2
ORLY
57
4
Financhill
Back

China Pharma Holding 10K Form

Buy
52

CPHI
China Pharma Holding

Last Price:
$2.20
Seasonality Move:
-12.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPHI News And Ratings

See the #1 stock for the next 7 days that we like better than CPHI

CPHI Financial Statistics

Sales & Book Value

Annual Sales: $4.5M
Cash Flow: $-138.8K
Price / Cash Flow: 12.76
Annual Sales: $2.14
Price / Book: 1.04

Profitability

EPS (TTM): -2.14000
Net Income (TTM): $-4.6M
Gross Margin: $-2M
Return on Equity: -61.79%
Return on Assets: -31.27%

China Pharma Holding Earnings Forecast

Key China Pharma Holding Financial Ratios

  • The Gross Profit Margin over the past 21 years for CPHI is -43.84%.
  • The Selling, General & Administrative Expenses for CPHI have been equal to 51.08% of Gross Profit Margin.
  • The Research & Development expenses have been 6.27% of Revenue.
  • The Net Earning history of CPHI is -104.58% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

China Pharma Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPHI
Website: chinapharmaholdings.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 0.56
Quick Ratio: 0.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CPHI Technical Analysis vs Fundamental Analysis

Buy
52
China Pharma Holding (CPHI) is a Buy

Is China Pharma Holding a Buy or a Sell?